I’m right with you Pokey. While I did learn that they are confident that they have an effective vaccine candidate as is (‘memory’ still to be determined), the rest only unnecessarily muddied the waters. Rescheduling the cc would have been far less disruptive to both ‘we chickens’ and the share price. But both will recovery over the next week as all reflect on what we DID hear. Clinical trials can’t start soon enough. We need their single dose, easy to transport and manage vaccine more than ever. Think billions of people around the globe who won’t have access to refrigerated supply chains. Go Generex...we need you to be successful.